Status: Not yet recruiting
Puerto Rico Embolization of the Middle Meningeal Artery for the Treatment of Chronic Subdural Hematoma Trial (PREMMA)
Puerto Rico Embolization of the Middle Meningeal Artery (PREMMA) trial is a multi-center, parallel, prospective, superiority, randomized controlled trial with concealed allocation comparing reoperation rates and neurological outcomes in patients with chronic subdural hematoma that receive treatment via embolization of the middle meningeal artery versus surgical evacuation via burr hole trephination or craniotomy.
Participants needed: 658
Trial details
Age: 21+Biological sex: AllType: InterventionalSponsor: Juan M. Ramos AcevedoUpdated: May 7, 2025
Eligibility criteria
Age ≥ 21 [+7]
Acute subdural hematoma [+14]